Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women

Clinical Science

Volumn 100, Issue 2, 2001, Pages 207-213

  Teede, H J ^a   McGrath, B P ^a   Turner, A ^a   Majewski, H ^a  

^a DANDENONG HOSPITAL   (Australia)

Author keywords

Collagen; Nitric oxide; Oestrogen; Progesterone

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN; KILOGEST; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE DEFICIENCY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE VOLUME;

AGED; ANTHROPOMETRY; COLLAGEN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NORETHINDRONE; OMEGA-N-METHYLARGININE; PLATELET AGGREGATION; POSTMENOPAUSE;

EID: 0035115930     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000221     Document Type: Article

References (38)

1. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort
2. A prospective study of postmenopausal estrogen therapy and coronary heart disease
3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial
4. Estrogen modulates responses of atherosclerotic coronary arteries
5. Oestrodiol inhibits smooth muscle cell proliferation of pig coronary artery
6. Regression of atherosclerosis in female monkeys
7. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis, which may explain the increased risk of venous thromboembolism
8. Oral contraceptives, blood clotting and thrombosis
9. Postmenopausal hormone replacement therapy increases both coagulation activity and fibrinolysis
10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
11. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
12. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women
13. The estrogen receptor is present in human megakaryocytes
14. Primary hemostasis during women's life cycle measured by Thrombostat 4000
15. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
16. The electronic aggregometer: A novel device for assessing platelet behaviour
17. A quick method for screening platelet dysfunction using the whole blood Lumi-aggregometer
18. Ability of whole blood aggregometer to detect platelet hyperaggregability
19. ACP broadsheet 122: Platelet function testing
20. Quantitation of platelet mass during aggregation in the electronic (Wellcome) whole blood aggregometer
21. The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters
22. A stearic acid rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males
23. Effect of different sample preparation methods on the results of the impedance technique in the study of platelet hyper- and hypo function in whole blood
24. Effects of blood dilution on electrical impedance aggregometry
25. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed non-insulin dependent diabetes mellitus
26. Whole blood impedance platelet aggregometry and ischaemic heart disease
27. Simultaneous measurement of platelet aggregation and the release reaction in platelet rich plasma and whole blood
28. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions
29. The effect of different regimens of oestrogens on the clotting and fibrinolytic system of the postmenopausal woman
30. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - A beneficial effect on atherogenesis and thrombus formation?
31. Increased mean platelet volume after oestrogen replacement therapy
32. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in postmenopausal women
33. Progestins and androgens
34. Antiatherosclerotic activity of drugs in relation to nitric oxide function
35. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: A response similar to that observed in adults
36. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function
37. The biological and pharmacological role of nitric oxide in platelet function
38. Effects of 17Bestradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis